IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 66 filers reported holding IMMUNIC INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,603 | -76.7% | 245,308 | -60.3% | 0.00% | -81.0% |
| Q2 2023 | $1,550,397 | +92.1% | 617,688 | +14.0% | 0.02% | +90.9% |
| Q1 2023 | $807,060 | +9.3% | 541,651 | +2.7% | 0.01% | -8.3% |
| Q4 2022 | $738,686 | -66.6% | 527,633 | -62.3% | 0.01% | -52.0% |
| Q3 2022 | $2,211,209 | +4.5% | 1,397,868 | +129.2% | 0.02% | -40.5% |
| Q2 2022 | $2,116,000 | +32.5% | 609,765 | +331.5% | 0.04% | +121.1% |
| Q1 2022 | $1,597,000 | -12.9% | 141,319 | -26.2% | 0.02% | +46.2% |
| Q4 2021 | $1,834,000 | +365.5% | 191,612 | +676.0% | 0.01% | +225.0% |
| Q1 2021 | $394,000 | -67.7% | 24,692 | -69.0% | 0.00% | -63.6% |
| Q4 2020 | $1,218,000 | +46.9% | 79,664 | +78.4% | 0.01% | -35.3% |
| Q3 2020 | $829,000 | -25.2% | 44,643 | -51.2% | 0.02% | -52.8% |
| Q2 2020 | $1,108,000 | +1553.7% | 91,419 | +708.9% | 0.04% | +1100.0% |
| Q1 2020 | $67,000 | -39.1% | 11,301 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $110,000 | -3.5% | 11,301 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $114,000 | – | 11,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 1,000,000 | $1,400,000 | 0.88% |
| Omega Fund Management, LLC | 1,788,160 | $2,503,424 | 0.84% |
| COMMODORE CAPITAL LP | 1,800,000 | $2,520 | 0.38% |
| Ikarian Capital, LLC | 650,000 | $910,000 | 0.22% |
| Gratus Capital, LLC | 1,668,294 | $2,335,612 | 0.19% |
| GREAT POINT PARTNERS LLC | 632,184 | $885,058 | 0.17% |
| Parkman Healthcare Partners LLC | 459,770 | $643,678 | 0.17% |
| Anson Funds Management LP | 664,935 | $930,909 | 0.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 350,656 | $490,918 | 0.14% |
| COWEN AND COMPANY, LLC | 791,024 | $1,107,433 | 0.12% |